• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIFECELL STRATTICE RECONSTRUCTIVE TISSUE MATRIX, 10 X 10, FIRM; MESH, SURGICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIFECELL STRATTICE RECONSTRUCTIVE TISSUE MATRIX, 10 X 10, FIRM; MESH, SURGICAL Back to Search Results
Catalog Number 1010002
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Cellulitis (1768)
Date of Event 03/19/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Our investigation of lot sp100543 includes: manufacturing review: review of information as reported, review of the device history records and complaint history records associated with lot sp100543.Results of evaluation: no failure detected.Review of the lot processing history and the complaint history records for lot sp100543 was unremarkable.There were no processing deviations or nonconformance related to the nature of this complaint.The lot met qc criteria for release, including mechanical testing results.As of 27 mar 2018, no other complaint has been reported to lifecell against lot sp100543.As of 27 mar 2018, of the (b)(4) devices released to finished goods for lot sp100543, all (b)(4) devices were distributed with 85 devices reported to be implanted.Based on our internal review of the device processing history, the lot met qc criteria for product release.Lot sp100543 was aseptically processed, terminally sterilized within process parameters, and met qc release criteria.No deviation was encountered in association with the reported event.No other complaint has been reported to lifecell against lot sp100543.
 
Event or Problem Description
It was reported that due to incarcerated inguinal hernia, the female patient underwent ventral hernia repair with strattice on (b)(6) 2018.The patient presented with postoperative cellulitis.The cause of the cellulitis is unknown as the surgeon is unsure if the reaction is related to the strattice.Surgical intervention to remove the strattice mesh was scheduled but a date was not provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STRATTICE RECONSTRUCTIVE TISSUE MATRIX, 10 X 10, FIRM
Common Device Name
MESH, SURGICAL
Manufacturer (Section D)
LIFECELL
1 millennium way
branchburg NJ 08876
MDR Report Key7432666
Report Number1000306051-2018-00048
Device Sequence Number13781552
Product Code FTM
UDI-Device Identifier00818410010096
UDI-Public00818410010096
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
K070560
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 04/12/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date05/31/2019
Device Catalogue Number1010002
Device Lot NumberSP100543
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/19/2018
Initial Report FDA Received Date04/16/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age51 YR
-
-